Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Appendix
Available only for authorised users
Literature
1.
Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood 140:1229–1253CrossRefPubMedPubMedCentral
2.
Hu Z, Medeiros LJ, Chen Z, Chen W, Li S, Konoplev SN et al (2017) Mantle cell lymphoma With MYC rearrangement: a report of 17 patients. Am J Surg Pathol 41:216–224CrossRefPubMed
3.
Wang L, Tang G, Medeiros LJ, Xu J, Huang W, Yin CC et al (2021) MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma. Haematologica 106:1381–1389CrossRefPubMed
4.
Setoodeh R, Schwartz S, Papenhausen P, Zhang L, Sagatys EM, Moscinski LC et al (2013) Double-hit mantle cell lymphoma with MYC gene rearrangement or amplification: a report of four cases and review of the literature. Int J Clin Exp Pathol 6:155–167PubMedPubMedCentral
5.
Cheng J, Hashem MA, Barabé F, Cloutier S, Xi L, Raffeld M et al (2021) CCND1 genomic rearrangement as a secondary event in high grade B-Cell lymphoma. HemaSphere 5:e505CrossRefPubMed
Metadata
Title
Should We Test for MYC-Rearrangement in Mantle Cell Lymphoma?—An Illustrative Report
Authors
Tarunpreet Saini
Praveen Sharma
Man Updesh Singh Sachdeva
Nabhajit Mallik
Anshu Anshu
Shailja Rathore
Anand Balakrishnan
Amanjit Bal
Rudra Narayan Swain
Gaurav Prakash
Sreejesh Sreedharanunni
Publication date
25-02-2024
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-024-01739-5
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits